Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

NASDAQ:ACLS - US0545402085 - Common Stock

81.92 USD
+1.01 (+1.25%)
Last: 8/27/2025, 8:00:01 PM
79.7777 USD
-2.14 (-2.62%)
After Hours: 8/27/2025, 8:00:01 PM
Fundamental Rating

7

ACLS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ACLS has a decent growth rate and is not valued too expensively. This makes ACLS very considerable for quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year ACLS was profitable.
In the past year ACLS had a positive cash flow from operations.
ACLS had positive earnings in each of the past 5 years.
Each year in the past 5 years ACLS had a positive operating cash flow.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

ACLS has a Return On Assets of 11.97%. This is amongst the best in the industry. ACLS outperforms 83.64% of its industry peers.
ACLS's Return On Equity of 15.50% is amongst the best of the industry. ACLS outperforms 81.82% of its industry peers.
The Return On Invested Capital of ACLS (12.23%) is better than 84.55% of its industry peers.
ACLS had an Average Return On Invested Capital over the past 3 years of 21.34%. This is significantly above the industry average of 10.98%.
The 3 year average ROIC (21.34%) for ACLS is well above the current ROIC(12.23%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 11.97%
ROE 15.5%
ROIC 12.23%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACLS's Profit Margin of 17.69% is amongst the best of the industry. ACLS outperforms 80.91% of its industry peers.
In the last couple of years the Profit Margin of ACLS has grown nicely.
The Operating Margin of ACLS (17.81%) is better than 75.45% of its industry peers.
In the last couple of years the Operating Margin of ACLS has grown nicely.
The Gross Margin of ACLS (44.90%) is comparable to the rest of the industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.81%
PM (TTM) 17.69%
GM 44.9%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACLS is creating value.
Compared to 1 year ago, ACLS has less shares outstanding
The number of shares outstanding for ACLS has been reduced compared to 5 years ago.
The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 7.46 indicates that ACLS is not in any danger for bankruptcy at the moment.
ACLS's Altman-Z score of 7.46 is fine compared to the rest of the industry. ACLS outperforms 69.09% of its industry peers.
ACLS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.35, ACLS belongs to the top of the industry, outperforming 80.91% of the companies in the same industry.
ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
ACLS has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: ACLS outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 7.46
ROIC/WACC1.04
WACC11.78%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 6.01 indicates that ACLS has no problem at all paying its short term obligations.
ACLS's Current ratio of 6.01 is amongst the best of the industry. ACLS outperforms 84.55% of its industry peers.
ACLS has a Quick Ratio of 4.26. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.26, ACLS is in the better half of the industry, outperforming 76.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.01
Quick Ratio 4.26
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ACLS have decreased strongly by -28.37% in the last year.
Measured over the past years, ACLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.54% on average per year.
The Revenue for ACLS has decreased by -19.38% in the past year. This is quite bad
Measured over the past years, ACLS shows a very strong growth in Revenue. The Revenue has been growing by 24.30% on average per year.
EPS 1Y (TTM)-28.37%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-27.1%
Revenue 1Y (TTM)-19.38%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-24.16%

3.2 Future

ACLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.02% yearly.
ACLS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.47% yearly.
EPS Next Y-31.52%
EPS Next 2Y-17.23%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue Next Year-22.15%
Revenue Next 2Y-9.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.75, which indicates a correct valuation of ACLS.
Based on the Price/Earnings ratio, ACLS is valued cheaper than 89.09% of the companies in the same industry.
ACLS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.14.
ACLS is valuated rather expensively with a Price/Forward Earnings ratio of 19.44.
Based on the Price/Forward Earnings ratio, ACLS is valued a bit cheaper than 73.64% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.80, ACLS is valued at the same level.
Industry RankSector Rank
PE 15.75
Fwd PE 19.44
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACLS is valued cheaper than 90.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ACLS is valued cheaply inside the industry as 83.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.95
EV/EBITDA 9.4
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ACLS has an outstanding profitability rating, which may justify a higher PE ratio.
ACLS's earnings are expected to grow with 24.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.24
EPS Next 2Y-17.23%
EPS Next 3Y24.02%

More info and screens

0

5. Dividend

5.1 Amount

ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (8/27/2025, 8:00:01 PM)

After market: 79.7777 -2.14 (-2.62%)

81.92

+1.01 (+1.25%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/amc
Inst Owners104.93%
Inst Owner Change-0.82%
Ins Owners0.94%
Ins Owner Change8.65%
Market Cap2.57B
Analysts72.86
Price Target99.26 (21.17%)
Short Float %16.72%
Short Ratio9.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)107.85%
Min EPS beat(2)51.76%
Max EPS beat(2)163.95%
EPS beat(4)4
Avg EPS beat(4)59.67%
Min EPS beat(4)2.16%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)36.38%
EPS beat(12)12
Avg EPS beat(12)29.49%
EPS beat(16)16
Avg EPS beat(16)28.03%
Revenue beat(2)2
Avg Revenue beat(2)2.57%
Min Revenue beat(2)2.12%
Max Revenue beat(2)3.02%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)3.02%
Revenue beat(8)7
Avg Revenue beat(8)1.46%
Revenue beat(12)11
Avg Revenue beat(12)2.07%
Revenue beat(16)15
Avg Revenue beat(16)2.39%
PT rev (1m)11.71%
PT rev (3m)16.25%
EPS NQ rev (1m)35.73%
EPS NQ rev (3m)53.4%
EPS NY rev (1m)25.39%
EPS NY rev (3m)24.99%
Revenue NQ rev (1m)7.09%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)4.4%
Revenue NY rev (3m)4.4%
Valuation
Industry RankSector Rank
PE 15.75
Fwd PE 19.44
P/S 2.87
P/FCF 20.95
P/OCF 18.61
P/B 2.52
P/tB 2.52
EV/EBITDA 9.4
EPS(TTM)5.2
EY6.35%
EPS(NY)4.21
Fwd EY5.14%
FCF(TTM)3.91
FCFY4.77%
OCF(TTM)4.4
OCFY5.37%
SpS28.52
BVpS32.54
TBVpS32.54
PEG (NY)N/A
PEG (5Y)0.24
Profitability
Industry RankSector Rank
ROA 11.97%
ROE 15.5%
ROCE 13.92%
ROIC 12.23%
ROICexc 23.5%
ROICexgc 23.5%
OM 17.81%
PM (TTM) 17.69%
GM 44.9%
FCFM 13.71%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ROICexc(3y)45.35%
ROICexc(5y)37.49%
ROICexgc(3y)45.35%
ROICexgc(5y)37.49%
ROCE(3y)24.29%
ROCE(5y)20.95%
ROICexcg growth 3Y-3.61%
ROICexcg growth 5Y39%
ROICexc growth 3Y-3.61%
ROICexc growth 5Y39%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.24
Cap/Depr 91.25%
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion 78.35%
Profit Quality 77.5%
Current Ratio 6.01
Quick Ratio 4.26
Altman-Z 7.46
F-Score6
WACC11.78%
ROIC/WACC1.04
Cap/Depr(3y)109.12%
Cap/Depr(5y)96.53%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.07%
Profit Quality(5y)99.84%
High Growth Momentum
Growth
EPS 1Y (TTM)-28.37%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-27.1%
EPS Next Y-31.52%
EPS Next 2Y-17.23%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.38%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-24.16%
Revenue Next Year-22.15%
Revenue Next 2Y-9.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.8%
EBIT growth 3Y18.31%
EBIT growth 5Y54.17%
EBIT Next Year-45.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.07%
FCF growth 3Y-3.13%
FCF growth 5YN/A
OCF growth 1Y-45.47%
OCF growth 3Y-2.13%
OCF growth 5YN/A